Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126574212 | 12657421 | 2 | F | 20160714 | 20160909 | 20160816 | 20160919 | EXP | US-ALEXION PHARMACEUTICALS INC.-A201605863 | ALEXION | 5.70 | YR | M | Y | 0.00000 | 20160919 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126574212 | 12657421 | 1 | PS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 600 MG, Q3W | D | 125166 | 600 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | Q3W | |||||
126574212 | 12657421 | 2 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 300 MG, Q3W | D | 125166 | 300 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | Q3W |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126574212 | 12657421 | 1 | Haemolytic uraemic syndrome |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126574212 | 12657421 | DE |
126574212 | 12657421 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126574212 | 12657421 | Inappropriate schedule of drug administration | |
126574212 | 12657421 | Incorrect dose administered |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126574212 | 12657421 | 1 | 20160714 | 20160801 | 0 |